Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Tumor-Agnostic 1Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 115Myelodysplastic Syndromes 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Leukemia 74Hodgkin Disease 73Leukemia, Lymphocytic, Chronic, B-Cell 72Multiple Myeloma 71Lymphoma, Non-Hodgkin 71Lymphoma 66Myeloproliferative Disorders 54Graft vs Host Disease 50Lymphoma, Follicular 49Lymphoma, Mantle-Cell 47Leukemia, Myeloid, Accelerated Phase 47Lymphoma, Large B-Cell, Diffuse 46Congenital Abnormalities 46Leukemia, Myelomonocytic, Chronic 44Lymphoma, B-Cell, Marginal Zone 43Hematologic Neoplasms 43Leukemia, Myelogenous, Chronic, BCR-ABL Positive 42Leukemia, Myeloid, Chronic-Phase 41Burkitt Lymphoma 40Primary Myelofibrosis 39Blast Crisis 38Neoplasms, Plasma Cell 37Lymphoma, Large-Cell, Immunoblastic 32Waldenstrom Macroglobulinemia 25Myelodysplastic-Myeloproliferative Diseases 24Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24Lymphoma, T-Cell, Cutaneous 23

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Tacrolimus × Clear all
NCT03680092 2025-10-02

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

University of California, San Diego

Phase 2 Completed
43 enrolled 10 charts
Other hematologic neoplasm

Graft vs Host Disease, Neoplasms, Hematologic Neoplasms

NCT01871441 2025-05-16

Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Thomas Jefferson University

Phase 2 Terminated
4 enrolled 10 charts
Tumor-Agnostic

Neoplasms

NCT02566304 2025-04-24

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
35 enrolled 14 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00857389 2020-04-07

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
60 enrolled 15 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡